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Abstract 
Garlic has been investigated extensively for health benefits, resulting in more than one thousand publications over the last 
decade alone.  It is considered one of the best disease preventive foods, based on its potent and varied effects. Midlife risk 
factors for cardiovascular diseases, such as high serum total cholesterol, raised LDL, increased LDL oxidation, increased 
platelet aggregation, impaired fibrinolysis, hypertension and homocystinemia are important risk factors for dementia in later 
years. These risk factors play a major role in the genesis of atherosclerosis of vital arteries causing both cardiovascular and 
cerebrovascular disease.  Garlic is best known for its lipid lowering and anti-atherogenic effects. Possible mechanisms of 
action include inhibition of the hepatic activities of lipogenic and cholesterogenic enzymes that are thought to be the genesis 
for dyslipidemias, increased excretion of cholesterol and suppression of LDL-oxidation.  Oxidative stress caused by increased 
accumulation of reactive oxygen species (ROS) in cells has been implicated in the pathophysiology of several 
neurodegenerative diseases including Alzheimer's disease (AD). Several studies have demonstrated the antioxidant properties 
of garlic and its different preparations including Aged Garlic Extract (AGE). AGE and S-allyl-cysteines (SAC), a bioactive and 
bioavailable component in garlic preparations have been shown in a number of in vitro studies to protect neuronal cells 
against beta-amyloid (A ) toxicity and apoptosis. Thus the broad range of anti-atherogenic, antioxidant and anti-apoptotic 
protection afforded by garlic may be extended to its neuroprotective action, helping to reduce the risk of dementia, including 
vascular dementia and AD.
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Introduction 
Garlic and its preparations have been widely recognized 
as agents for prevention and treatment of cardiovascular 
and other metabolic diseases, atherosclerosis,       
hyperlipidemia, thrombosis, hypertension, dementia,   
cancer and diabetes [1]. The medicinal use of garlic has a 
long history. Over the centuries, garlic has acquired a 
special position in the folklore of many cultures as a 
formidable prophylactic and therapeutic medicinal agent 
[2]. Its uses as a remedy for heart disease, tumors, and 
headaches are documented in the Egyptian Cordex Ebers 
dating from 1550 BC (2, 3). Garlic is mentioned in the 
Bible and has been a traditional treatment in many 
countries notably the Near East, China, and India [2]. 
Garlic has attracted particular attention of modern 
medicine because of its widespread use around the world 
and the cherished belief that it helps to maintain good 
health by warding off illness and providing more vigor. 
Recently, health benefits of garlic as a neuroprotective 
agent are beginning to emerge [4]. This review discusses 
the possible mechanisms of therapeutic actions of garlic 
and its preparations.  The neuroprotective effects of garlic 
may be attributed to its three interrelated anti-
atherogenic, antioxidant and anti-apoptotic properties. 
 
Garlic preparations and their bioactive constituents 
Raw garlic homogenate has been the major preparation 
of garlic subjected to intensive scientific study, because it 
is the most common method of garlic consumption. Raw 
garlic homogenate is essentially the same as the aqueous 
garlic extract which has been used in various scientific 
studies.  Allicin (allyl 2-propene thiosulfinate or Diallyl 
thiosulfinate was long thought to be the principal bioactive 
compound present in aqueous extract or raw garlic 
homogenate [5]. When garlic is chopped or crushed, 
allinase enzyme, present in garlic is activated and acts on 
alliin (present in whole garlic) to produce allicin [6]. Other 
important sulfur-containing compounds present in garlic 
homogenate are allyl methyl thiosulfonate, 1-propenyl allyl 
thiosulfonate and -L-glutamyl-S-alkyl-L-cysteine [7]. The 
enzyme allinase responsible for converting alliin (S-allyl 
cysteine sulfoxide) to allicin is inactivated by heat [1]. 
Thus the water extract of heat treated garlic contains 
primarily alliin.  Although thiosulfinates such as allicin have 
long been thought to be active compounds due to the 
characteristic odor, it is not necessary for garlic 
preparations to contain odorous compounds to be 
effective.  They decompose and disappear during any 
processing [8]. 
  
Garlic products have become more popular in the last 
decade. Market research conducted in United States 
(1998) showed that garlic products were the most popular 
of all 91 dietary supplements [9]. Dozens of brands on 
store shelves can be classified into four groups:  garlic oil, 
garlic oil macerate, garlic powder and aged garlic extract 
(AGE). 
 
Garlic oil:  Medicinally used garlic oil is prepared by 
steam distillation process.  Distilled garlic oil consists of a 
variety of sulfides such as diallyl disulfide (DADS) and 
diallyl trisulfide (DAT) [6]. Whole garlic cloves ground in 
water are distilled by heat or extracted by an organic 
solvent (i.e. hexane) to obtain fractionated oil. Water 
soluble compounds are totally eliminated by this process. 
Allicin is also completely eliminated from the oil [1]. 
 
Garlic oil macerate: Oil macerate products are made of 
encapsulated mixtures of whole garlic cloves ground into 
vegetable oil.  During the manufacturing process, some 
alliin is converted to allicin.  Because allicin is unstable and 
decomposes quickly, oil macerate preparations contain 
allicin – decomposed compounds such as dithiins, ajoene 
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and sulfides, residual amounts of alliin and other 
constituents in garlic [10]. 
 
Garlic powder: Garlic cloves are sliced or crushed, dried 
and pulverized into powder.  The main sulfur compound in 
both raw garlic and garlic powder is alliin [11]. Garlic 
powder contains no allicin, possibly accounting for its 
instability [12]. 
 
Aged garlic extract: Another widely studied garlic 
preparation is AGE. Sliced raw garlic stored in 15-20% 
ethanol for 20 months is referred to as AGE. This whole 
process is supposed to cause considerable loss of allicin 
and increased activity of certain newer compounds such 
as S-allylcysteine (SAC), S-allyl mercaptocysteine, allixin, 
saponins and selenium which are stable, highly 
bioavailable and significantly antioxidant. SAC is one of the 
most active ingredients in AGE [13]. SAC is a safe 
compound and its biological effects are well researched. 
The US National Cancer Institute tested SAC toxicity as 
compared to other typical garlic compounds and found 
that SAC is less toxic than allicin and DADS [13]. 
 
The neuroprotective effects of garlic 
The nervous system is the major communication 
network in the human body. Its normal functioning is 
strongly dependant on the maintenance of its structural 
integrity and many complex metabolic processes.  
Accordingly, the processes that disrupt normal structure 
or metabolism, or both, are capable of producing 
neurological disease. The degenerative diseases of the 
central nervous system (CNS) encompass a heterogeneous 
group of disorders characterized by spontaneous, 
progressive degeneration of neurons in specific regions of 
the brain, spinal cord, or both. The neurodegenerative 
disorders include Alzheimer’s Disease, Parkinson’s Disease, 
Huntington's Disease and Amyotrophic Lateral Sclerosis 
(motor neuron disease). AD is the most common cause of 
dementia in the elderly with cerebrovascular disease and 
several less common neurodegenerative disorders 
accounting for most of the remaining cases [14]. 
 
Antiatherogenic- neuroprotective effects of garlic 
Atherosclerosis is a complex disease, characterized by 
an extensive inflammatory, fibro-fatty, proliferative 
response to damage of  the arterial wall involving several 
cell types, particularly muscle cells, monocyte-derived 
macrophages, T-lymphocytes and platelets [15]. 
Hyperlipidemia constitutes a major pathological factor that 
predisposes for atherosclerosis. The medicinal value of 
garlic is best known for its lipid lowering and anti-
atherogenic effect [16]. 
 
Cardiovascular disease is associated with multiple risk 
factors such as raised serum total cholesterol, elevated 
low density lipoprotein (LDL) and an increase in LDL 
oxidation, increased platelet aggregation, impaired 
fibrinolysis, hyper homocystinemia, and hypertension [17]. 
 
Growing evidence supports a strong and likely causal 
association between cardiovascular disease (CVD) and its 
risk factors with incidence of cognitive decline and AD [18-
21]. Individuals with subclinical CVD are at higher risk for 
dementia and AD [18]. Based on both cross sectional and 
longitudinal epidemiology studies, there are statistically 
significant correlations between the prevalence of AD and 
several other diseases or symptoms.  These include 
diabetes, hypercholesterolemia, hypertension, 
hyperhomocysteinemia, dietary intake of  saturated fats,  
elevated cholesterol, alcohol consumption, smoking, 
physical inactivity, atrial fibrillation, atherosclerotic 
disease,  and plasma concentrations of some hemostatic 
factors [19]. Newman et al [20]  have observed that the 
incidence of dementia was higher in those with CVD, 
particularly in the subgroup with peripheral artery disease  
(PAD) suggesting that extensive peripheral atherosclerosis 
is a risk factor for AD. Bergman C et al [21] recently 
reviewed both observational and clinical studies regarding 
the association between anti-hypertensive, lipid lowering 
and anti-diabetic medications and the risk of impaired 
cognition, dementia or AD.  They proposed that early 
interventions at reducing these cardiovascular risk factors 
may have an impact on future incidence of several 
cognitive deficits including AD. 
 
Next to AD, vascular dementia is the second most 
common form of senility in the elderly suggesting that 
dyslipidemia may be relevant to the occurrence of 
dementia with a vascular component [22]. Studies have 
also found that baseline high density lipoprotein levels 
were lower and triglyceride levels were higher in elderly 
men who developed dementia with vascular components 
[18]. 
 
The risk of cognitive decline in community dwelling was 
highest among APOE4 allele carriers who had high 
cholesterol levels, high fibrinogen levels, or diabetes [23]. 
Saczynski et al [24] recently raised the possibility that 
various lipoprotein components of cholesterol may be 
differentially associated with dementia. In addition to the 
role of cholesterol in A  generation, interactions of 
cholesterol with A  and its role in the pathogenesis of AD 
have been shown i.e. A  affects cholesterol dynamics in 
neurons, and altered cholesterol metabolism in turn leads 
to neurodegeneration with abnormally phosphorylated tau 
[25]. 
 
The pathways from elevated LDL cholesterol to the 
development of dementia or stroke are unclear, but 
promotion of atherosclerosis by LDL-cholesterol may 
provide a link.  High concentrations of LDL-cholesterol are 
known to be independently associated with coronary heart 
disease [17] and carotid artery atherosclerosis [26] which 
in turn may lead to cognitive decline through cerebral 
embolism or hypoperfusion [27]. A recent epidemiological 
study by Kin et al [28] provides compelling evidence that 
carotid atherosclerosis is associated with brain atrophy. 
The authors suggest that carotid atherosclerosis may be a 
useful morphological index of brain atrophy. 
 
Lipid peroxidation may also be a major factor in the 
aging process and hypercholesterolemic diets may lead to 
microglial activation [29] and beta-amyloid [A ] plaque 
deposition (30). Thus cholesterol oxidation in the brain 
may be particularly relevant to the pathogenesis of 
vascular dementia with mixed pathology (i.e. AD with 
concomitant stroke). 
 
In our laboratory we demonstrated that the metabolism 
of glycosaminoglycans  (GAGs)   is  affected in 
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hypercholesterolemia with increased sulfated fractions 
[31]  Inclusion of garlic  protein in the diet of cholesterol 
fed rats significantly decreased the concentration of total 
GAG in the heart  and aorta, especially of the sulfated 
fractions. This is possibly due to the increased activity of 
GAG degrading enzymes such as  -glucuronidase,  -N-
acetyl hexosaminidase aryl sulfatase and hyaluronidase. 
Concentration of total GAG was measured by estimating 
uronic acid concentration in the papain digestion of dry 
defatted tissue.  GAG fractions were estimated in the total 
GAG solution after digestion with hyaluronidase and 
chondroitinase ABC followed by ion exchange separation 
and estimation of uronic acid in the elutes. The activity of 
 -glucuronidase and  -N acetyl hexosaminidase was 
assayed by measuring the release of paranitrophenol from 
paranitrophenol   –D-glucuronide and paranitrophenol – -
acetylglucoseamide.  Hyaluronidase activity was assayed 
by estimating N-acetylhexoseamine liberated from 
hyaluronic acid. Aryl sulfatase was assayed by measuring 
the liberated catechol from paranitrocatechol sulfate. 
 
Sulfated GAGs are implicated in lipid accumulation in 
developing lesions because of their ability to bind plasma 
lipoproteins, especially LDL. The neurotoxic effects of 
several amyloidogenic peptides including A  in AD is 
potentiated by increased sulfated GAGs [32]. 
 
Hypertension may contribute to cognitive decline seen 
in AD by causing cerebral small vessel pathology and 
increasing the number of neurofibrillar tangles and 
amyloid plaques [33]. 
 
Elevated plasma homocysteine is an independent risk 
factor for cardiovascular disease, stroke and dementia 
including AD [34].  Homocysteine thiolactone, a highly 
reactive free radical which thiolates LDL particles is formed 
in hyperhomocysteinemia.  The modified LDL particles 
tend to aggregate, are endocytosed by macrophages, and 
increase the tendency for atherogenesis [34]. 
 
Platelet aggregation superimposed on an atherosclerotic 
vessel is an antecedent event causing total blockage of 
blood flow leading to thromboembolic diseases, 
hypoperfusion, stroke, and dementia [15]. 
 
The medicinal value of garlic is best known for its lipid 
lowering and antiatherogenic effects. In animal 
experiments, garlic extracts have been shown to lower 
plasma lipid and cholesterol in rats, rabbits, chickens and 
swine [35-41]. 
 
Moreover a number of studies have similarly shown that 
garlic and garlic preparations significantly reduced plasma 
lipids, especially total cholesterol and LDL-cholesterol in 
humans [42-45]. Aside from the reported antiplatelet 
aggregation, garlic stimulated fibrinolytic activity [46-52]. 
 
The protective effect of garlic on atherosclerosis has 
been attributed to its capacity to reduce lipid content in 
arterial wall. Animal studies have shown that 
supplementation  of garlic in the diet depressed  the 
hepatic activities of lipogenic  and  cholesterogenic 
enzymes  such as malic enzyme, glucose-6-phosphate 
dehydrogenase and 3 hydroxy-3-methylglutarylCoA (HMG 
CoA) reductase [36]. 
  The activity of hepatic G6PD and malic enzyme was 
assayed by measuring the rate of formation of NADPH 
using glucose -6- phosphate and malate respectively as 
substrates. The activity of hepatic HMG –CoA reductase 
was determined by the ratio of HMG-CoA to mevalonic 
acid in fresh rat liver homogenate. The lower the ratio is 
the higher the enzyme activity. Studies in our laboratory 
and elsewhere have shown the formation of protein 
internal disulfides by thiol disulfide exchange reaction to 
be the cause of this inactivation [53, 54].  This was 
demonstrated by identifying the interaction between sulfur 
compounds and garlic components using chromatographic 
methods and by tryptic peptide analysis. 
 
Gebhhardt et al [55] and Yeh et al [56] have reported 
the multiple inhibitory effects of garlic extracts on 
cholesterol biosynthesis in cultured rat hepatocytes. The 
inhibition of HMG-CoA reductase by garlic has also been 
confirmed in a recent study from our laboratory [38]. In 
animal studies, we have also demonstrated that 
administration of garlic increased the hepatic degradation 
of cholesterol to bile acids [37]. Bile acids were estimated 
by the enzymatic procedure using 3  hydroxy steroid 
dehydrogenase and monitoring the rate of formation of 
NADH using cholic acid as standard. 
 
Mehrzia et al [57] examined the acute effects of a 
partially purified fraction from garlic on plasma glucose 
and cholesterol levels in rats, and confirmed that aqueous 
extract of garlic contained an active fraction different from 
S-allyl cysteine sulfoxide, exerting both glucose and 
cholesterol lowering activity. Control (vehicle H2O) or 
garlic extract treated groups at 100 – 120 mg protein / kg 
body weight were intraperitoneally injected, and glucose, 
cholesterol, insulin, and nitric oxide metabolite levels were 
determined after short term duration of six hours. The 
mechanism of action seemed to involve nitric oxide (NO), 
which increased time and dose dependently. The garlic 
effects were abolished by diphenyleneiodonium chloride 
(DPI = 1 mg / kg body weight), a specific inhibitor of nitric 
oxide production, suggesting the involvement of 
constitutive nitric oxide synthesis. LDL isolated from 
human subjects given AGE and aqueous garlic extract was 
found to be significantly more resistant to oxidation (58). 
Allicin was identified initially as the compound responsible 
for anti-atherosclerotic effect [5].  However recent in vitro 
studies revealed that water soluble organic sulfur 
compounds, especially SAC present in AGE and DADS 
present in garlic oil, are also potent inhibitors of 
cholesterol synthesis [8]. AGE has consistent effects on 
risk factors for CVD including cholesterol [59, 60].  
 
In some of these studies, blood SAC level was measured 
in the subjects as a compliance marker. The blood SAC 
level in the group taking supplements was significantly 
higher than that of the placebo group [60, 61].  It is clear 
that SAC is bioavailable because it was absorbed into the 
blood and is therefore active in the human body.  Budoff 
et al have demonstrated that AGE retards the progress of 
coronary artery calcification and Weiss et al reported that 
AGE improves homocysteine-induced endothelial 
dysfunction in macro- and micro-circulation [62, 63]. Yeh 
et al [64] have reported that garlic extract attenuates 
hyperhomocysteinemia.   Increased amounts of 
homocysteine exerts several pro-atherosclerotic effects, 
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including damaging the endothelium of blood vessels. 
Thus the decrease in levels of elevated homocysteine by 
garlic ingestion suggests its protective role against CVD. 
 
The formation of atherosclerotic plaque leads to 
narrowing of vessel walls when proliferative changes 
occur. This proliferation is due to liberation of various 
growth factors by macrophages and platelets [65]. Platelet 
aggregation superimposed on atherosclerotic vessel leads 
to thrombosis (coronary, cerebral or peripheral vascular) 
leading to ischemia of the tissue.  Srivastava et al [49] 
reported that aqueous extract of garlic inhibits platelet 
aggregation induced by ADP, epinephrine, collagen, and 
calcium ionophore A23187 in a dose dependant manner. 
Sendl et al [66] demonstrated that chloroform / acetone 
extracts of fresh garlic inhibit cyclo-oxygenase activity 
directly in cell-free assays, with the acetone extract being 
more effective.  Ajoene, another garlic derivative, has 
been shown to inhibit in vitro platelet aggregation in 
different animals, i.e. cow, dog, guinea pig, horse, 
monkey, rabbit, and rat [46]. 
 
Teraniski et al [47] have also demonstrated that ajoene 
inhibits platelet aggregation in vitro. Chan et al  [67] in a 
recent study have shown that diallyl trisulfide (DAT) rich 
garlic oil (GO) supplement at 5 or 50 mg/kg body weight 
when fed to Sprague Dawley rats significantly prolonged 
bleeding time and thrombin time and enhanced 
anticoagulation factor activity, such as antithrombin III 
and protein C. The authors postulated that the 
anticoagulant action of DAT-rich GO was due to inhibition 
and/or inactivation of thrombin. Another garlic component, 
sodium 2-propenyl thiosulfate was found to modulate 
cyclo-oxygenase activity in canine platelets thus 
preventing their aggregation [48]. The studies of Qi et al 
[68] demonstrated that the mechanism of inhibition of 
platelet aggregation by garlic constituents may also be via 
the inhibition of calcium mobilization. The antiplatelet 
aggregation mechanism of garlic has been attributed to 
reduced formation of thromboxanes, inhibition of 
phospholipase activity, and lipoxygenase products found in 
platelets [49]. Garlic has a positive response in the 
inhibition of platelet aggregation in both healthy subjects 
and subjects with cardiovascular disease [61,69,70].     
Fibrinolysis is also enhanced by garlic, resulting in 
dissociation of clots and thrombi. 
 
In human studies, Bordia et al [50-52] consistently 
showed the positive fibrinolytic activity of garlic. They 
reported that chronic (three weeks to three months) 
administration of GO increased fibrinolytic activity ranging 
from 36% to 130% in healthy patients as well as patients 
who had had an acute myocardial infarction [50, 51]. 
Studies by other investigators have also found the same 
results [71, 72].   Epidemiological studies support a strong 
association between hypertension, CVD, and dementia 
[18, 19]. The antihypertensive effects of garlic have been 
studied but remain controversial.  In a 1994 meta-analysis 
by Silagy et al [73] assessing the effect of garlic on 
hypertension, three trials showed significant reductions in 
systolic blood pressure (>7.7 mm Hg reduction), and four 
trials showed reduction in diastolic blood pressure (>5 mm 
Hg reduction) with garlic treatment compared with 
placebo. All the trials used the same dried garlic powder 
preparation (Kwai). This meta-analysis suggests that the 
garlic powder preparation may be of some clinical use in 
subjects with mild hypertension. In a more recent meta-
analysis [74] 23 placebo-controlled trials were analyzed. 
Only three trials showed a statistically significant reduction 
in diastolic blood pressure, and one showed a statistically 
significant reduction in systolic blood pressure in patients 
treated with garlic compared with placebo. Rashid et al 
[75] suggested that the mechanism of antihypertensive 
action of garlic is due to its prostaglandin-like effects, 
which decrease peripheral vascular resistance. The 
gamma-glutamyl cysteines are the compounds in garlic 
that may lower blood pressure, as indicated by their ability 
to inhibit angiotensin-converting enzyme in vitro [66]. 
 
Aortic stiffening is as much an important risk factor in 
cardiovascular morbidity and mortality and 
cerebrovascular incidents. Elevated aortic stiffness induces 
high systolic blood pressure, augmented pulse pressure 
with increased ventricular afterload, reduced 
subendocardial blood flow and augmented pulsatile stress 
in the peripheral arteries [76]. In populations consuming 
garlic for long periods (  300 mg of garlic powder/day for 
  2 years) attenuation of an age-related increase in aortic 
stiffness has been observed [77]. This suggests a 
protective effect on the elastic properties of the aorta 
related to aging in humans. Ahmad et al [78] have 
recently reported that AGE and SAC prevent formation of 
advanced glycation end products (AGEs). Accumulation of 
AGEs lead to crosslinking of matrix proteins with altered 
function. Amagase et al [8] reported that among the 
different garlic products, AGE which is odorless and rich in 
antioxidants was found to be very effective to modulate 
cardiovascular risk factors in both clinical and preclinical 
settings. 
 
Table 1 The key points about the proposed mechanism 
of antiatherogenic and related effects of garlic. 
•Depressed hepatic activities of lipogenic and cholesterogenic 
enzymes 
•Increased hepatic degradation of cholesterol to bile acids 
•Decreased plasma LDL- cholesterol levels 
•Antithrombotic and anti-platelet aggregation effects due to 
reduced formation of thromboxanes, inhibition of 
phospholipase activity, lipoxygenase products formation in 
platelets and of  calcium mobilization 
•Stimulates fibrolytic activity 
•Lowers plasma homocysteine levels 
•Antihypertensive action and decrease in peripheral vascular 
resistance due to its prostaglandin like effects and ability to 
inhibit angiotensin–converting enzyme 
•Attenuation of aortic stiffness and thus protective effect on 
the elastic properties of the aorta 
Human clinical trials on antiatherogenic and 
related effects of garlic 
The Agency for Healthcare Research and Quality 
[AHRQ] in their evidence report dated October, 2000, [79] 
summarized the effects of garlic on cardiovascular risk 
factors and disease, the association between garlic and 
cancer, and possible adverse effects of garlic. 
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English and non-English citations were identified 
through February, 2000, from 11 electronic databases, 
references of pertinent article reviews, manufacturers, and 
technical experts. They limited the review of 
cardiovascular- related effects to randomized, controlled 
trials in humans that lasted at least four weeks and 
compared garlic with placebo, no garlic, or another active 
agent. There were 45 randomized controlled trials (RCTs) 
lasting at least four weeks that tested the effects of garlic 
on cardiovascular-related end points. The results indicate 
that  37 randomized trials  (all but one in adults) 
consistently showed that compared with placebo, various 
garlic preparations led to small statistically significant 
reductions in total cholesterol at one month (range of 
average pooled reductions 1.2 to 17.3 milligrams per 
deciliter [mg/dL] ) and three months (range of average 
pooled reductions 12.4 to 25.4 mg/dL).  Eight trials with 
outcomes at six months showed no significant reductions 
of garlic compared with placebo. Changes in LDL levels 
and triglycerides mirrored total cholesterol results; no 
significant changes in HDL levels were found. Twenty- 
seven small, randomized, placebo-controlled trials (all but 
one in adults) reported mixed but never large effects of 
various garlic preparations on blood pressure outcomes. 
Ten small trials (all but one in adults) of short duration 
showed the effects of various garlic preparations on 
platelet aggregation, and mixed effects on plasma 
viscosity and fibrinolytic activity. 
 
Rahman et al [16] critically reviewed human trials which 
were conducted since 1993. Only those trails which were 
conducted for a minimum period of two weeks and that 
addressed the following parameters had been included: 
(a) cholesterol- lowering effects, (b) inhibition of platelet 
aggregation (c) lowering of blood pressure and (d) other 
cardioprotective properties. They reported that since 1993, 
44% of the clinical trials have indicated a reduction in total 
cholesterol and all the seven clinical trials on the inhibition 
of platelet aggregation showed positive response in both 
healthy subjects and subjects with CVD . Mixed results 
were obtained in the area of blood pressure and oxidative 
stress reduction where very few trials addressed these 
issues. The different composition and quality of sulfur 
compounds of different garlic preparations, unknown 
active constituents and their bioavailability, inadequate 
randomization, selection of inappropriate subjects, and the 
short duration of trials could account for the inconsistent 
findings. 
(1998–2007) showing the hypolipidemic effects of 
garlic. Thus with the emerging literature on the 
association between traditional cardiovascular risk factors, 
dementia, and AD, the anti-atherogenic and related 
protection afforded by garlic may  be extended to its 
neuroprotective action, helping reduce the risk for 
cerebrovascular disease and dementia. However, further 
well-designed randomized, larger clinical trials of longer 
duration using well standardized preparations of garlic 
need to be conducted to support these effects. 
 
Table 2 gives a summary of major clinical trials during 
the last decade (1998-2007) 
 
 
 
 
Antioxidant-neuroprotective effects of garlic 
Reactive oxygen species (ROS), or free radicals, have 
been implicated in mediating various pathological 
processes such as cancer, cardiovascular, 
neurodegenerative and inflammatory diseases [80]. 
Oxidative stress caused by increased accumulation of ROS 
in cells has been implicated in the pathophysiology of 
several neurodegenerative diseases including AD [81]. 
Common pathogenetic mechanisms for both 
atherosclerotic disease and AD, such as inflammation and 
the generation of ROS suggest a causal link [19]. Thus 
identification of modifiable risk factors for dementia 
becomes a research priority and early intervention aimed 
at reducing those cardiovascular risk factors a therapeutic 
imperative. 
 
ROS include free radicals and non-radical species. The 
free radicals carry an unpaired electron and are unstable 
and reactive. They include superoxide, nitric oxide and the 
most reactive and toxic ROS, the hydroxyl radical. Non-
radical oxidants include hydrogen peroxide, singlet 
oxygen, and ozone, which form free radicals through 
various chemical reactions. The reactions relevant to cell 
injury mediated by free radicals include lipid peroxidation 
of membranes, DNA fragmentation, and cross-linking of 
proteins. 
 
However, cells have also developed several enzymatic 
and non-enzymatic systems to inactivate free radicals. The 
major antioxidant enzymes are superoxide dismutase 
(SOD), catalase, and glutathione peroxidase [8]. Free 
radicals are neutralized by scavengers (vitamins E, A, C 
and  carotene), and the ability of Cu++ and Fe+++ to 
form free radicals is minimized by binding the ions to 
carrier proteins (ferritin and ceruloplasmin respectively). 
 
Garlic has been reported to be effective against diseases 
of which ROS are considered to be the main cause [8,58]. 
Oxidative modification of LDL increases the risk of 
atherosclerosis, cardiovascular and cerebrovascular 
disease. Oxidized LDL acquires new antigenic properties 
that are recognized by the host immune system as 
"foreign". Thus oxidized LDL produces several new 
biologic responses which contribute to the thickening and 
narrowing of arteries, the principal event in atherosclerosis 
[82]. Borek [80] and Amagase [8] have cited several 
studies which have demonstrated the antioxidant 
properties of garlic. Raw garlic homogenate augmented 
endogenous antioxidants along with reduction of basal 
lipid peroxidation in rat heart, liver and kidney in a dose 
dependant manner [83]. Lau et al [82] provided 
experimental evidence showing that several garlic 
compounds can suppress LDL oxidation in vitro. Short 
term supplementation of garlic in human subjects has 
demonstrated an increase resistance of LDL to oxidation. 
Their data suggest that suppressed LDL oxidation may be 
one of the mechanisms that accounts for the beneficial 
effects of garlic in cardiovascular health. AGE exerted its 
antioxidant action by scavenging reactive oxygen species 
and enhancing the cellular antioxidants like reduced 
glutathione (GSH), superoxide dismutase (SOD), catalase 
(CAT) and glutathione peroxidase (GPx) of vascular 
endothelial cells [84,85]. Popov et al [86] observed the 
antioxidant effect of the aqueous extract from a  
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Table 2  A summary of major clinical trials during the last decade (1998-2007) 
Durak et al (2004)   Turner et al (2004)   Kannar et al (2001)   Yeh et al (2001)  
Method
Not placebo  
controlled  
Double-blind 
placebo controlled  
Double-blind placebo 
controlled  
Double-blind placebo controlled  
Preparation AGE  Garlic  Powder  Garlic  Powder  AGE  
Subject 
Selection
Hypercholesterolemic  Healthy  Hypercholesterolemic  Hypercholesterol-emic  
No. of 
subjects
n= 23  n=  75  n=  46  n=  34  
Duration 4 mo  12  wks  12  wks  5  mo  
Results
  TC  
  LDL-C  
  VLDL-C  
  TAG  
   TAG  
no change in  
TC, LDL-C,  
HDL-C  
  TC  
  LDL-C  
no change in  
TAG, HDL-C  
   TC  
   LDL-C  
no change in TAG, HDL-C  
 
dehydrated garlic powder preparation by using 
photochemiluminescence on the Cu2+ initiated oxidation  
of LDL. The formation of conjugated diene, which 
accompanies the lipid peroxidation process, was detected 
photometrically. AGE and its constituent SAC have a 
similar preventive effect against Cu2+ initiated oxidation 
of LDL taken from human subjects who consume AGE 
[87]. Horie et al [88] have demonstrated that AGE 
prevents the formation of thiobarbituric acid reactive 
substances (TBARS) and fluorescent substances during 
lipid peroxidation of rat liver microsomes. Imai et al (84) 
compared the antioxidant properties of three garlic 
preparations and organosulfur compounds in garlic. AGE 
inhibited the emission of low level chemiluminescence and 
the early formation of TBARS in a liver microsomal fraction 
initiated by t –butyl hydroperoxide. However, the water 
extracts of raw and heat treated garlic enhanced the 
emission of low level chemiluminiscence. In vitro studies 
have shown that AGE improves circulation and blood 
properties by preventing lipid peroxidation and hemolysis 
in oxidized erythrocytes [89]. 
 
Nuclear factor –  (NF- B) is a transcription factor that is 
regulated by the redox state of the cell and implicated in 
the inducible expression of a variety of genes involved in 
oxidative stress and cellular responses to stress. NF- B is 
thought to play a role in atherogenesis because minimally 
modified LDL has been shown to activate NF- B activation 
[90]. Geng et al [91] have demonstrated that AGE and 
SAC inhibit TNF-  and hydrogen peroxide induced 
activation of NF- B in human T cells. Inhibition of NF- B 
by AGE in part by preventing oxidative modification of 
LDL, further supports the role of AGE in helping to prevent 
atherogenesis and lowering the risk of heart disease and 
stroke. Gorinstein et al [92] investigated and found that 
both raw and boiled garlic enhances plasma antioxidant 
activity and improves plasma lipid metabolism in 
cholesterol fed rats.  It was found that garlic boiled for 20 
minutes has the same bioactivity as raw garlic in its 
antioxidant and protein spectra. The selenium and copper 
content of raw garlic is not altered by boiling. 
 
Pari et al [93] have recently demonstrated that the 
garlic compound diallyltetrasulfide [DTS] has 
cytoprotective and antioxidant activity against cadmium 
[Cd] induced toxicity. Cd is a neurotoxic metal, which 
induces oxidative stress and membrane disturbances in 
nerve system. In rats exposed to Cd (3 mg/kg/day) 
subcutaneously for 3 weeks, a significant increase in the 
levels of lipid peroxidation (LPO) and protein carbonyls 
along with a significant decrease in the levels of GSH and 
total sulphydryl groups (TSH) and the activities of 
acetylcholinesterase (AChE), SOD, CAT, G Px, GST, 
membrane bound enzymes (ATPases: Na+ K+-ATPase , 
Mg2+-ATPase and Ca2+ATPase) were observed in the 
brain tissue. Oral administration of DTS (40 mg/kg/day) 
with Cd significantly diminished the levels of LPO and 
protein carbonyls and increased the activity of ATPases 
and antioxidant enzymes in the brain. These results 
suggest that DTS protects the brain function from the 
toxic effects of Cd. 
 
In another study, Pari et al [94] have reported the 
cytoprotective and antioxidant role of DTS on Cd- induced 
renal injury. In vitro studies with kidney cell lines (vero 
cells) showed that incubation of DTS (5–50 μg/ml) with Cd 
(10 μM) significantly reduced the cell death induced by Cd 
(μM) indicating its cytoprotective property. Further, the 
flow cytometric assessment on the level of intracellular 
reactive oxygen species using a fluorescent probe 2’ 
7’dichlorofluorescein diacetate (DCFDA) confirmed the Cd 
induced intracellular oxidative stress in vero cells, which 
was significantly suppressed by DTS (40 μg/ml). These 
antioxidant cytoprotective effects of compounds from 
garlic against Cd toxicity attain great significance from the 
fact that several reports suggest the role of heavy metals 
in neuronal degeneration [95,96]. 
 
Liu et al [97] reported that GO prevents tributyltin (TBT) 
induced oxidative damage in vivo and in vitro. They found 
that both reactive oxygen species (ROS) production and 
malondialdehyde (MDA) content decreased in mice 
pretreated with GO. The number of cells with damaged 
DNA in unprotected mice increased significantly compared 
with that in GO protected mice. In human FL (human 
amniotic cells) cell studies, TBT induced intracellular ROS 
generation was significantly inhibited after FL cells were 
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pretreated with GO, and the TBT induced cytotoxic effects 
were also prevented by GO. 
  
The high antioxidant level in AGE helps prevent the 
oxidant damage that occurs during ischemia or 
reperfusion.  Ischemia followed by reperfusion results in 
an increased production of free radicals and oxidant stress 
that may lead to neuronal death by apoptosis that 
contributes to the development of dementia following 
stroke. 
 
Saleem et al [98] have reported that AGE effectively 
modulates neuro-behavioural and neuro-chemical changes 
in focal ischemia, most probably by virtue of its 
antioxidant properties. In their study, the middle cerebral 
artery [MCA] of male Wistar rats was occluded for 2 hours 
using intraluminal 4-O monofilament and reperfusion was 
allowed for 22 hours. Middle cerebral artery occlusion 
(MCAO) caused significant depletion in GSH and its 
dependant enzymes (GPx, GR and GST) and significant 
elevation of MDA, glutamate, and aspartate. The activities 
of Na +, K+, ATPase, SOD, and CAT were decreased 
significantly by MCAO. The neuro-behavioural activities 
(group strength, spontaneous motor activity, and motor 
coordination) were also decreased significantly in the 
MCAO group.  All of the alterations induced by ischemia 
were significantly attenuated by pretreatment with AGE 
(500 mg/ml/kg body wt., i.p) 30 minutes before the 
induction of MCAO and correlated well with histopathology 
by decreasing the neuronal cell death following MCAO and 
reperfusion. In a similar study, Gupta et al [99] observed 
the neuroprotective effects of GO on ischemia and 
reperfusion induced cerebral injury. Global cerebral 
ischemia was induced by occluding right and left common 
carotid arteries for ten minutes followed by reperfusion for 
24 hours. Cerebral infarct size was estimated using 
triphenyltetrazolium staining. Mitochondrial TBARS assay 
was employed as an index of oxidative stress.   
Administration of GO before global cerebral ischemia 
markedly reduced cerebral infarct size and attenuated 
impairment in short term memory and motor coordination. 
The protective effects of AGE was reported in a preclinical 
study of ischemia, and the findings showed that treatment 
with SAC attenuated damaging reactive oxygen species 
and prevented brain injury, reducing infarct volume (100). 
 
These data indicate the antioxidant properties of garlic 
in preventing myocardial and cerebrovascular incidents 
and dementia. 
 
Human clinical trials on antioxidant effects of garlic 
Antioxidant effect of garlic in humans is not well 
studied. Rahman et al [16] have recently reviewed the 
literature on clinical trials related to the antioxidant 
properties of garlic. Seven studies since 1993 were 
identified. They reported that five of the studies showed a 
decrease in oxidative stress [45,101-104] while two 
studies showed no significant change in oxidative stress 
parameters [70,105]. Further randomized, placebo–
controlled, larger clinical trials need to be conducted to 
firmly establish the antioxidant properties of garlic. 
 
 
 
Table 3  The key points about the mechanism of 
antioxidant effects of garlic 
•Scavenging ROS, inhibiting LDL oxidation 
•Protection of endothelial cell integrity by inhibition of lipid 
peroxidation induced injury 
•Inhibits homocysteine thiolactone formation 
•Enhancement of cellular reduced glutathione levels (GSH) 
•Enhancement of cellular scavenging enzymes such as 
superoxide dismutase (SOD) catalase (CAT) and glutathione 
peroxidase (GPx) 
•Inhibition of nuclear factor-  B activation 
•Modulating neurobehavioral changes in reversible focal 
ischemia and reperfusion induced cerebral injury by virtue of 
its antioxidant properties 
 
 
Table 4  A summary of major clinical trials during the last 
decade [1998-2007] showing the antioxidant properties of 
garlic. 
 
Durak et 
al (2004)  
Durak et 
al (2004)  
Dhawan 
et al               
( 2004 )  
Dillon  et 
al ( 2002)  
Method
Not 
placebo 
controlled  
Not 
placebo 
controlled  
Not 
placebo  
controlled  
Not 
placebo  
controlled  
Preparat
ion
AGE  AGE  
Garlic 
Pearls  
AGE  
Subject 
selectio
n
Atheroscl
erotic  
Hyperchol
esterol-
emic  
Hypertens
ive  
smoking 
&   
non 
smoking  
No. of 
subjects
n= 11  n=  23  n=  20  
n= not 
specified  
Duration 6 mo  4  mo  2  mo  14  days  
Results
  
biomarker
s  
of 
oxidative  
stress in 
blood  
  
biomarker
s  
of 
oxidative  
stress in 
blood  
  
biomarker
s  
of 
oxidative  
stress in 
blood  
  
biomarker
s  
of 
oxidative  
stress in 
blood  
AGE  Aged garlic extract 
Anti-apoptotic-neuroprotective effects of garlic 
Apoptosis occurs through two well recognized pathways 
in cells. Both effector mechanisms of apoptosis are 
associated with caspase activation and include the intrinsic 
or mitochondria mediated effector mechanism and the 
extrinsic or death receptor mediated effector mechanism 
[106]. The mitochondrial membrane constitutes the 
battleground on which opposing signals combat to seal the 
cells fate. 
Increased mitochondrial permeability and dissipation of 
the electrochemical gradient or membrane potential via 
opening of the mitochondrial permeability transition pore 
triggers cell death by releasing apoptogenic factors from 
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within the mitochondria, with subsequent cytochrome C 
release, caspase activation, and ultimately execution of 
apoptosis [107]. The release of cytochrome C is believed 
to be a key event in apoptosis, and it is regulated by the 
genes of the BCL2 family.   Some members of this family 
(eg. BCL2, BCLXl, BCL-W) inhibit apoptosis by preventing 
the release of cytochrome C, whereas others such as BAD, 
BAX, BID and BIM promote apoptosis by favoring 
cytochrome C release [106]. The mechanism of   amyloid-
induced neuronal apoptosis sequentially involves C-Jun N 
terminal kinase activation, BCL-W down regulation and 
release of apoptogenic factor second mitochondrial 
derived activator of caspase, followed by cell death [108]. 
Recently, Biswas et al [109] have demonstrated that BIM 
is elevated in AD neurons and is required for -amyloid 
induced apoptosis. 
 
After exposing rat pheochromocytoma (PC12) cells to 
A , a significant increase in ROS preceded apoptotic 
events [110]. AGE, SAC, and DADS have been shown in a 
number of in vitro studies to protect neuronal cells against 
A   toxicity and apoptosis [110–112]. AGE and SAC not 
only suppressed the generation of ROS but also 
attenuated caspase-3 activation, DNA fragmentation, and 
eventually protected neurons against A   induced 
apoptosis [110]. 
 
Koh et al [112] have studied the effects of diallyl 
disulfide (DADS), a garlic derived compound, on the 
viability of neuronal cells and cell signals  including 
phosphatidylinositol 3- kinase (P13 K), glycogen synthase 
kinase-3 (GSK-3) cytochrome c, caspase -3 and poly (ADP- 
ribose) polymerase (PARP) in PC12 cells neuronally 
differentiated by nerve growth factor. To evaluate the 
protective effects of DADS on oxidative stress–induced 
nPC12 cells, the viability of the cells (pretreated with 
DADS for two hours vs not pretreated) was evaluated 24 
hours after exposure to100  M H2O2 for 30 min. 
Compared to the cells treated with 100 M H2O2 only, 
pretreatment of the cells with 20 M DADS before 
exposure to 100 M H2O2 increased the viability and 
induced activation of P13K, inactivation of GSK-3 and 
inhibition of cytochrome C release, caspase-3-activation 
and PARP cleavage. These results indicate the 
neuroprotective effect of DADS by its anti-apoptotic 
properties. 
 
 In a recent study Chauhan et al [113] have reported 
the amelioration of early cognitive deficits by AGE in 
Alzheimer’s transgenic mice. Feeding of AGE prevented 
deterioration of hippocampal-based memory tasks in these 
mice, suggesting that AGE has a potential for preventing 
AD progression. Thus the anti-apoptotic properties of 
garlic and its constituents may also contribute to its 
neuroprotective effect. 
 
Contraindications, adverse effects, interactions 
Animal studies with rats in our laboratory have shown 
that prolonged feeding of high levels of raw garlic in rats 
has resulted in anemia, weight loss, and failure to grow 
due to lysis of red blood cells [114]. Raw garlic juice at a 
dose of 5 ml/kg has resulted in death due to stomach 
injury [115]. Chronic administration of garlic powder (50 
mg/day) resulted in inhibition of spermatogenesis in rats. 
Reduced concentration of sialic acid in the testes, 
epididymis and seminal vesicles together with decreased 
leydig cell function reflects anti-androgenic effects of garlic 
[116]. All the above mentioned toxicity reports cannot be 
explained to the full extent but for interactions of specific 
enzymes with the sulfoxides. Relatively few side effects 
were reported in human clinical trials using garlic and its 
preparations. Most of the reported side effects were 
nonspecific. The ingestion of one or two cloves of garlic 
per day is considered safe in adults [117]. The most 
common side effect of ingested garlic is offensive breath 
and body odor. Consumption of excessive amounts of 
garlic, especially on an empty stomach, can cause 
gastrointestinal upset, flatulence, and changes in the 
intestinal flora [74, 118]. There have been reports of 
allergic dermatitis, burns, and blisters from topical 
application of raw garlic. Whether adverse effects occur 
more commonly with certain preparations than others was 
not established. Furthermore, the causality of the adverse 
effects was unclear, except for breath and body odor, and 
the expected frequency of adverse effects was not 
determined. Garlic appears to have no effect on drug 
metabolism [119], although recent studies in healthy 
volunteers show conflicting results related to garlic’s effect 
on protease inhibitor pharmacokinetics [120,121]. A few 
reports of adverse effects related to bleeding and 
interaction with other drugs such as warfarin and aspirin 
have also been reported [122,123]. It has been suggested 
that patients taking anticoagulants use caution when 
taking garlic because of its anti-thrombotic properties 
[74,120]. It seems prudent to stop taking high doses of 
garlic seven to ten days before surgery because garlic can 
prolong bleeding time and has been associated (in one 
case report) with spontaneous spinal epidural hematoma 
[74,124]. 
 
Conclusion
Garlic has many health benefits and has been 
traditionally used worldwide over the centuries.  The 
wealth of scientific literature supports the proposal that 
garlic and its preparations help in preventing or reducing 
the risk of cardiovascular ailments, stroke, and cancer. 
Recently the beneficial effects of garlic and its constituents 
on neuronal physiology and brain function are beginning 
to emerge. This review encompasses multiple health 
effects of garlic and its constituents with references to 
neuroprotection.  Further studies should be carried out to 
identify specific compounds from garlic that are 
responsible for most of its biological effects. 
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